The current study is a continuation of this research to further evaluate which of the rectal cancer-associated membrane proteins CEA, EpCAM, αvβ6, and uPAR is the most useful indicator of absence of residual vital cancer cells after neoadjuvant therapy. This evidence concerns the gene PLAUR and rectal cancer.